Bizily Scott 4
4 · 4D Molecular Therapeutics, Inc. · Filed Sep 26, 2025
Insider Transaction Report
Form 4
Bizily Scott
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-23$8.00/sh−2,407$19,256→ 7,596 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.
- [F2]Reflects 3,222 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.